Back to Journals » OncoTargets and Therapy » Volume 15

miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1 [Retraction]

Authors Luo X, He X, Liu X, Zhong L, Hu W

Received 21 November 2022

Accepted for publication 21 November 2022

Published 22 November 2022 Volume 2022:15 Pages 1407—1408

DOI https://doi.org/10.2147/OTT.S398523



Luo X, He X, Liu X, Zhong L, Hu W. Onco Targets Ther. 2020;13:7467–7477.

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of tumor images from Figure 6A with the same images from another article. Specially,

In addition, concerns were also raised regarding the alleged duplication of flow cytometry images from Figure 4A with the same images from other articles. Specifically,

It was also found cell colony images in Figures 5A and 5D appeared to have been duplicated. Specifically,

  • Figure 5A, NC, 0 Gy appears to have been duplicated with the same image for Figure 5D, mimic, 0 DDP (µM).
  • Figure 5D, mimic, 5 DDP (µM) appears to have been duplicated with the same image for Figure 5D, NC, 5 DDP (µM).
  • Figure 5D, mimic, 10 DDP (µM) appears to have been duplicated with the same image for Figure 5D, NC, 5 DDP (µM).

The authors did not respond to our queries and no explanation for the alleged image duplication was provided. The Editor requested to retract the article and the authors were notified of this.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.